filmov
tv
NEW DRUG APPLICATION | REGULATORY AFFAIR
Показать описание
NEW DRUG APPLICATION:
The NDA contains all of the information and data that the FDA requires for market approval of a drug.
A new drug application (NDA) includes enough information for the FDA to determine whether the new drug is safe and effective; whether the drug’s benefits outweigh its risks; whether the proposed drug label (package insert) is appropriate; and whether the drug manufacturing standards are adequate.
-----------------------------------------------------------------------------------------------------------------------
other videos in Regulatory Affair:
PHARMACEUTICAL COMPANY DISTRIBUTION RECORD-
0:00 Introduction
0:12 The Drug Development Process
2:09 New Drug Application (NDA)
3:59 NDA Classification
6:15 As outlined in Form FDA
7:23 NDA REVIEW PROCESS
The NDA contains all of the information and data that the FDA requires for market approval of a drug.
A new drug application (NDA) includes enough information for the FDA to determine whether the new drug is safe and effective; whether the drug’s benefits outweigh its risks; whether the proposed drug label (package insert) is appropriate; and whether the drug manufacturing standards are adequate.
-----------------------------------------------------------------------------------------------------------------------
other videos in Regulatory Affair:
PHARMACEUTICAL COMPANY DISTRIBUTION RECORD-
0:00 Introduction
0:12 The Drug Development Process
2:09 New Drug Application (NDA)
3:59 NDA Classification
6:15 As outlined in Form FDA
7:23 NDA REVIEW PROCESS
0:03:17
How does the FDA approve new drugs?
0:05:30
What is Investigational New Drug (IND) Application? | Regulatory Learnings | Drug Regulatory Affairs
0:06:46
Investigational New Drug Application: Key to Starting Clinical Trials | Regulatory Affairs
0:10:03
NEW DRUG APPLICATION | REGULATORY AFFAIR
0:46:00
Introduction to Investigational New Drug (IND) Applications (3/14) REdI 2017
0:58:49
Investigational New Drug Application (IND) Forms: Updates and Best Practices
0:03:17
How does the FDA approve new drugs?
0:36:55
Components of New Drug Application and Biologics License Application (5of15) REdI– May 29-30, 2019
0:06:29
New Drug Application (NDA): Key Components & FDA Approval
0:10:36
Abbreviated New Drug Application (ANDA) | Drug Regulatory Affairs
0:40:34
Demystifying the Investigational New Drug (IND) Application for Drugs and Biologics (3of14) REdI &ap...
0:04:19
Abbreviated New drug application|ANDA|pharmaceutical regulatory science|unit2|Sem 8 #ANDA
0:03:59
Step 5: How to submit an Investigational New Drug (IND) application to USFDA? | Regulatory Learnings
0:02:51
Regulatory Submissions and Applications
0:02:02
5 Things You Need to Know About the Drug Approval Process
0:02:11
The Generic Drug Approval Process
0:17:02
CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications
0:10:24
Regulatory Affairs Explained Episode 1: FDA, Application Types, Regulatory Pathways & More
0:11:02
NEW DRUG APPLICATION (NDA) | REGULATORY AFFAIRS | UNIT 3 | INDUSTRIAL PHARMACY 2 | B.PHARM | 7th SEM
0:55:25
Common Labeling Deficiencies and Tips for Generic Drug Applications
0:16:19
Referencing Approved Drug Products in ANDA Submissions (9of28) Generic Drugs Forum – Apr. 3-4, 2019...
0:35:51
Orange Book Exclusivity: Part II - Pediatric, Orphan, and GAIN
0:07:36
Investigational New Drug Application| INDA|pharmaceutical regulatory science| unit 2|Sem 8 #INDA
1:00:47
Understanding New Drug Applications (NDAs)
Комментарии